Xentuzumab (Anti-IGF-1)
Xentuzumab (Anti-IGF-1) is a recombinant a humanized monoclonal antibody that targets IGF ligands IGF-1 and IGF-2. Xentuzumab inhibits both of IGF-1 and IGF-2 growth-promoting signalling and suppresses AKT activation. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2457 |
Sku # | A2457-1mg*25 |
Pricing | 1mg*25, $4170.00 |